Corrigendum: Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study

Autor: Min Yuan, Zhongzheng Zhu, Wei Mao, Hui Wang, Hong Qian, Jianguo Wu, Xianling Guo, Qing Xu
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Frontiers in Oncology, Vol 11 (2022)
Druh dokumentu: article
ISSN: 2234-943X
DOI: 10.3389/fonc.2021.796625
Databáze: Directory of Open Access Journals